# Longitudinal Antimalarial Combinations in Uganda

> **NCT00123552** · PHASE3 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 601 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Amodiaquine+Artesunate
- **DRUG:** Amodiaquine+Sulfadoxine/Pyrimethamine
- **DRUG:** Artemether+Lumefantrine

## Key facts

- **NCT ID:** NCT00123552
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2006-06
- **Final completion:** 2008-12
- **Target enrollment:** 601 (ACTUAL)
- **Last updated:** 2020-06-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00123552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00123552, "Longitudinal Antimalarial Combinations in Uganda". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00123552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*